PEOPLE - Luminex makes appointment:
This article was originally published in Clinica
Luminex, an Austin, Texas-based bioassay developer has appointed Douglas Bryant as executive vice-president and COO. His remit will include the company's molecular diagnostics and bioscience subsidiaries. Mr Bryant, who has over 23 years' of industry experience, joins the firm from Abbott Vascular, Asia and Japan, where he was vice-president.
You may also be interested in...
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.
President Trump on 27 March finally pulled the trigger on using his powers under the Defense Production Act, forcing General Motors Co. to manufacture medical ventilators. The only thing is, GM is already doing that.
Theradaptive's “paint-like” regenerative therapeutic can be applied to any device to promote bone regrowth or regenerate tissue.